Diabetic ketoacidosis.
Calimag APP, Chlebek S, Lerma EV, Chaiban JT.
Dis Mon. 2023 Mar;69(3):101418. doi: 10.1016/j.disamonth.2022.101418. Epub 2022 May 14.
Pathophysiology of diabetes mellitus.
Guthrie RA, Guthrie DW.
Crit Care Nurs Q. 2004 Apr-Jun;27(2):113-25. doi: 10.1097/00002727-200404000-00003.
A systematic literature review on the burden of diabetic ketoacidosis in type 2 diabetes mellitus.
Wysham C, Bindal A, Levrat-Guillen F, Kostadinova D, Poon Y.
Diabetes Obes Metab. 2025 May;27(5):2750-2767. doi: 10.1111/dom.16282. Epub 2025 Mar 3.
Efficacy of Ketogenic Diets on Type 2 Diabetes: a Systematic Review.
Tinguely D, Gross J, Kosinski C.
Curr Diab Rep. 2021 Aug 27;21(9):32. doi: 10.1007/s11892-021-01399-z.
Euglycemic Ketoacidosis Associated with SGLT-2 Inhibitors in Non-diabetic Patients-A Narrative Review.
Garg R, Sood N, Bansal O, Hoskote A.
J Gen Intern Med. 2025 Feb;40(2):437-442. doi: 10.1007/s11606-024-09073-2. Epub 2024 Oct 1.
5-Year effects of a novel continuous remote care model with carbohydrate-restricted nutrition therapy including nutritional ketosis in type 2 diabetes: An extension study.
McKenzie AL, Athinarayanan SJ, Van Tieghem MR, Volk BM, Roberts CGP, Adams RN, Volek JS, Phinney SD, Hallberg SJ.
Diabetes Res Clin Pract. 2024 Nov;217:111898. doi: 10.1016/j.diabres.2024.111898. Epub 2024 Oct 20.
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.
Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB.
Diabetes Care. 2015 Sep;38(9):1687-93. doi: 10.2337/dc15-0843. Epub 2015 Jun 15.
Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case-report and review of the literature.
Oriot P, Hermans MP.
Acta Clin Belg. 2022 Feb;77(1):113-117. doi: 10.1080/17843286.2020.1780390. Epub 2020 Jun 16.
Continuous ketone monitoring: Exciting implications for clinical practice.
Kong YW, Morrison D, Lu JC, Lee MH, Jenkins AJ, O'Neal DN.
Diabetes Obes Metab. 2024 Dec;26 Suppl 7(Suppl 7):47-58. doi: 10.1111/dom.15921. Epub 2024 Sep 24.
Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Diabetic Ketoacidosis Among Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Colacci M, Fralick J, Odutayo A, Fralick M.
Can J Diabetes. 2022 Feb;46(1):10-15.e2. doi: 10.1016/j.jcjd.2021.04.006. Epub 2021 Apr 28.
